13G Filing: Visium Asset Management and Sage Therapeutics, Inc. (SAGE)

Page 7 of 11

Page 7 of 11 SEC Filing


CUSIP No. 78667J108 Page
7
of 11 Pages
(c) Number of Shares as to which person has:
(i) sole power to vote or to direct vote:
None
(ii) shared power to vote or to direct vote:
1,893,009 shares
(iii) sole power to dispose or direct disposition of:
None
(iv) shared power to dispose or to direct disposition of:
1,893,009 shares

JG Asset

(a) Amount Beneficially Owned:

By virtue of its position as General Partner
to VAM, JG Asset may be deemed to beneficially own the 1,893,009 shares of the Companys Common Stock beneficially owned by VAM.

(b) Percent of Class:

5.9%

(c) Number of Shares as to which person has:
(i) sole power to vote or to direct vote:
None
(ii) shared power to vote or to direct vote:
1,893,009 shares
(iii) sole power to dispose or direct disposition of:
None

Page 7 of 11 Pages

Follow Sage Therapeutics Inc. (NASDAQ:SAGE)

Page 7 of 11